Anti-CRISPR Small Molecule Discovered Using New High-Throughput Screening Platform

May 02, 2019

|

NEW YORK (GenomeWeb) – A team led by researchers at the Broad Institute and Brigham and Women's Hospital has developed a high-throughput platform for identifying small molecules that can disrupt the genome editing activity of CRISPR-Cas nucleases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Scott Gottlieb Goes Back to His Old Job

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Where No CRISPR Has Gone Before

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Two Leave Emory

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

This Week in Science

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Featured White Papers

Cell Engineering 101

Improved CRISPR Knockout Efficiency Using an Automated Optimization Workflow

CRISPR 101

Gene Knockouts: How CRISPR Is Used to Inactivate Genes

Jun

04

Featured Webinar

A CRISPR Study to Decipher the Role of Genetic Risk Variants in Glaucoma

This webinar will discuss a study that used CRISPR/Cas9 to engineer mice harboring risk variants associated with glaucoma in order to assess their functional relevance.

Jun

06

Featured Webinar

Accelerating Crop Research with High-Quality Affordable Genome Assemblies

This webinar will discuss the impact of affordable de novo genome assemblies on crop research.

Menu